It’s become a bit of a tradition for the Foundation to send a Thanksgiving note, and this year we’re excited to support projects that have evolved as part of ongoing work by researchers and the Foundation.
As you know, we seek new ideas and collaborative approaches and in 2021 that has translated into: continued work with NIH supporting next generation research, funding an initial site for breast cancer treatment clinical trial from the lab of Andrea Bild, Ph.D., at City of Hope, helping personalize radiation therapy for breast cancer with Heiko Enderling, Ph.D., at Moffitt Cancer Center, as well as extending funding to further the PhysiCell project developed by Paul Macklin, Ph.D.
The Foundation again hosted its annual October symposium, highlighting findings from collaborative research and hear a keynote address from the Jayne Koskinas Annual Keynote Speaker, Lisa M. Coussens, Ph.D. And I would be remiss if I didn’t thank Team TGM for its ongoing support.
Enjoy Thanksgiving with friends and loved ones and thank you again for being part of JKTG’s work. Happy Thanksgiving!
– Ted
Ted Giovanis, FHFMA, MBA
President and Founder
JKTG Foundation
Featured news
Ted’s Take: What is your role in health and health equity?
As we talk and plan for improvements in virtually anything, it’s important that we examine what our role in that process is and should be.
Ted’s Take: Medicare for all – HUH?
Around every national election, the phrase Medicare for All comes up. My reaction is simple: HUH? Here’s why?
JKTG-Funded Research Tackles Possible Way to Stop Spread of Breast Cancer
New JKTG Foundation-funded research identifies potential new immune system target to head off the spread of breast cancer cells. The work is from the Johns Hopkins Giovanis Institute and appears in the journal Oncogene.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133